Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Buntanetap tartrate by Annovis Bio for Alzheimer's Disease: Likelihood of Approval
Buntanetap tartrate is under clinical development by Annovis Bio and currently in Phase III for Alzheimer's Disease. According to GlobalData,...
Data Insights
Buntanetap tartrate by Annovis Bio for Parkinson's Disease: Likelihood of Approval
Buntanetap tartrate is under clinical development by Annovis Bio and currently in Phase III for Parkinson's Disease. According to GlobalData,...